Citi Pharma Limited (PSX:CPHL)

Citi Pharma Revenue

Citi Pharma had revenue of 3.08B PKR in the quarter ending March 31, 2026, a decrease of -7.67%. This brings the company's revenue in the last twelve months to 13.84B, up 6.68% year-over-year. In the fiscal year ending June 30, 2025, Citi Pharma had annual revenue of 13.15B with 6.00% growth.

• Revenue (ttm): 13.84B
• Revenue Growth: +6.68%
• P/S Ratio: 1.31
• Revenue / Employee: 26.07M
• Employees: 531
• Market Cap: 18.08B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	13.15B	744.28M	6.00%
Jun 30, 2024	12.41B	12.26M	0.10%
Jun 30, 2023	12.40B	2.62B	26.76%
Jun 30, 2022	9.78B	3.98B	68.75%
Jun 30, 2021	5.80B	2.27B	64.29%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 10, 2026

Data Sources Report a data error